Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, March 19, 2010, 4:41AM ET - U.S. Markets open in 4 hours and 49 minutes. Dow Up 0.42% Nasdaq  0.00%
Obagi Medical Products, Inc. (OMPI)On Mar 18: 12.28   0.00 (0.00%)  
MORE ON OMPI
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Obagi Medical Products, Inc.
3760 Kilroy Airport Way
Suite 500
Long Beach, CA 90806
United States - Map
Phone: 562-628-1007
Fax: 562-628-1008
Web Site: http://www.obagi.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

BUSINESS SUMMARY 
Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets topical aesthetic and therapeutic prescription skin care systems in the United States and internationally. It offers Obagi Nu-Derm System, which includes prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo-damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems that are used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System, a combination of prescription, OTC drugs, and adjunctive cosmetic skin care products to treat skin conditions resulting from sun damage and the oxidative damage of free radicals; and Obagi Professional-C products, a line of proprietary, non-prescription products, which consist of vitamin C serums used to reduce the appearance of damage to the skin caused by ultraviolet radiation and other environmental influences. The company also provides ELASTIderm Eye and Decolletage, which increase the elasticity and skin tone of eyes, face, neckline, and chest; CLENZIderm M.D. Systems used for the treatment of acne; Obagi Rosaclear System used for the treatment of rosacea; Tretinoin used for the treatment of acne; Refissa used for the treatment of fine facial lines, hyperpigmentation, and tactile roughness; Metronidazole, an antibiotic used for the treatment of rosacea in the United States; and Obagi Blue Peel System used for the treatment of fine lines, wrinkles, and hyperpigmentation. In addition, it licenses certain non-prescription product concepts to Japanese based pharmaceutical companies for sale in Japan under the Obagi trademark. Obagi Medical Products, Inc. sells its products through own domestic sales force and foreign distributors to dermatologists, plastic surgeons, and other physicians that are focused on aesthetic and therapeutic skin care. The company was founded in 1988 and is headquartered in Long Beach, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Obagi Medical Products, Inc.


    CORPORATE GOVERNANCE 
    Obagi Medical Products, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Mar-10 is better than 59.5% of Russell 3000 companies and 65.5% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Steven R. Carlson , 53
    Chief Exec. Officer, Pres
    $ 483.00K $ 0
    Mr. Preston S. Romm , 56
    Chief Financial Officer, Principal Accounting Officer, Exec. VP of Fin., Exec. VP of Operations and Exec. VP of Admin.
    $ 209.00K $ 0
    Ms. Laura B. Hunter ,
    VP of International Sales & Marketing, Sec. and Gen. Counsel
    $ 96.00K $ 0
    Mr. David S. Goldstein , 49
    Exec. VP of Global Sales & Field Marketing
    $ 292.00K $ 0
    Ms. Judith C. Hattendorf , 67
    Sr. VP of Product Devel.
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis